Cargando…
146 A 6-Week Study of the Efficacy and Safety of Ciclesonide Hydrofluoroalkane Nasal Aerosol in the Relief of Nasal Symptoms of Perennial Allergic Rhinitis
BACKGROUND: Ciclesonide hydrofluoroalkane nasal aerosol (CIC-HFA) is currently in development as a potential treatment for allergic rhinitis. The objective of this study was to determine the efficacy and safety of CIC-HFA compared to placebo in subjects with perennial allergic rhinitis (PAR). METHOD...
Autores principales: | Mohar, Dale, Berger, William, Raphael, Gordon, LaForce, Craig, Huang, Holly, Desai, Shailesh, Bode, Frederick, Karafilidis, John |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
World Allergy Organization Journal
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3513095/ http://dx.doi.org/10.1097/01.WOX.0000411891.75019.97 |
Ejemplares similares
-
154 A 26-Week Study Evaluating the Safety and Efficacy of Ciclesonide Hydrofluoralkane Nasal Aerosol in Subjects With Perennial Allergic Rhinitis
por: Berger, William, et al.
Publicado: (2012) -
169 The Efficacy of a Nasal Corticosteroid Ciclesonide for the Treatment of Serous Otitis Media in Atopic Children
por: Nsouli, Safa
Publicado: (2012) -
241 Nasal Cytology is Important in the Classification of Patients with Allergic and Non-Allergic Rhinitis
por: Mion, Olavo, et al.
Publicado: (2012) -
155 Omalizumab Improves Asthma but not Nasal Symptoms in Japanese Patients With Severe Allergic Asthma and Rhinitis
por: Nishihara, Fuyumi, et al.
Publicado: (2012) -
32 Peak Nasal Inspiratory Flow Levels in Children With Allergic Rhinitis and Their Health Related Quality of Life (HRQL)
por: Nagaraju, Major K.
Publicado: (2012)